Evidence map›Paper›PMID 24950732›Full record

ArticleCurrent HIV/AIDS reports2014

Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment.

C C Chang, V Sheikh, I Sereti, M A French

Abstract read
PubMed Publisher
In one paragraph

Article in Current HIV/AIDS reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. State of the art ofClinical and translational imaging · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Pulmonary coinfection byBMJ case reports · 2020
    Article
  13. Article
  14. Management of Advanced HIV Disease.Infectious disease clinics of North America · 2019
    Review
  15. Article
  16. Immune Reconstitution Disorders: Spotlight on Interferons.International journal of biomedical investigation · 2019
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

C C ChangDepartment of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, 3000, Australia.
V Sheikh
I Sereti
M A French
National Institute of Allergy and Infectious Diseases · USMonash University · AURoyal Perth Hospital · AU

Funding

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) DiseaseZIAAI001121 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SERETI, IRINI · 2010 to 2025
$27.2M
Intramural NIH HHS
6 · The paper itself

Abstract

An immune reconstitution disorder occurs in up to 40 % of severely immunodeficient HIV patients who commence antiretroviral therapy (ART), with an immune reconstitution inflammatory syndrome (IRIS) being encountered most commonly. Differences in the immunopathogenesis of an IRIS associated with different types of pathogen have become apparent but common features have also been defined. These include severe immunodeficiency prior to commencing ART associated with a high pathogen load and 'compensatory' immune responses, particularly innate immune responses, which inadequately control the pathogen and increase the risk of immunopathology as the immune system recovers on ART. Prevention of an IRIS may be achieved by optimising therapy for opportunistic infections before ART is commenced, delaying ART or using immunomodulatory therapy to prevent or suppress the immune response that causes the immunopathology. However, further clinical studies are required to examine these options in a systematic manner for the various types of IRIS.

Indexed as

Autoimmune DiseasesCryptococcosisHIV InfectionsHumansImmune Reconstitution Inflammatory SyndromeTuberculosis

Identifiers

PMID24950732
OpenAlexW1966790698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.